Literature DB >> 10740571

Genetics of diabetic nephropathy and microalbuminuria.

S C Bain1, T A Chowdhury.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10740571      PMCID: PMC1288066          DOI: 10.1177/014107680009300204

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  3 in total

1.  The 5'-end polymorphism of the aldose reductase gene is not associated with diabetic nephropathy in Caucasian type I diabetic patients.

Authors:  P H Dyer; T A Chowdhury; M J Dronsfield; D Dunger; A H Barnett; S C Bain
Journal:  Diabetologia       Date:  1999-08       Impact factor: 10.122

2.  Creutzfeldt-Jakob disease in a young woman.

Authors: 
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

3.  Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study.

Authors:  A R Andersen; J S Christiansen; J K Andersen; S Kreiner; T Deckert
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

  3 in total
  5 in total

1.  Preparation and characterization of polyclonal antibodies against ARL-1 protein.

Authors:  Jun-Fei Jin; Liu-Di Yuan; Li Liu; Zhu-Jiang Zhao; Wei Xie
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

2.  Relationship between C peptide and chronic complications in type-2 diabetes mellitus.

Authors:  Ramazan Sari; Mustafa Kemal Balci
Journal:  J Natl Med Assoc       Date:  2005-08       Impact factor: 1.798

Review 3.  Cost-effective strategies in the prevention of diabetic nephropathy.

Authors:  Jonathan D Rippin; Anthony H Barnett; Stephen C Bain
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 4.  Gene discovery in diabetic nephropathy.

Authors:  David A Savage; Stephen C Bain; Amy Jayne McKnight; A Peter Maxwell
Journal:  Curr Diab Rep       Date:  2007-04       Impact factor: 5.430

5.  HLA-DRB1*03 as a risk factor for microalbuminuria in same duration of type 1 diabetes: a case control study.

Authors:  Dovilė Ražanskaitė-Virbickienė; Evalda Danytė; Rimantas Žalinkevičius
Journal:  BMC Nephrol       Date:  2016-03-31       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.